110 related articles for article (PubMed ID: 16312828)
21. Epirubicin/vinorelbine adjuvant chemotherapy in young women with breast cancer is associated with preservation of menstrual function.
Zekri JM; El-Helw LM; Purohit OP; Hatton MQ; Coleman RE
Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):513-6. PubMed ID: 18513930
[TBL] [Abstract][Full Text] [Related]
22. 5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study.
Barni S; Visini M; Piazza E; Ionta MT; Ardizzoia A; Arnoldi E; Fava S; Pinotti G; Torretta F; Corradini G; Villa S; Nosenzo AM; Massidda B; Cazzaniga ME
Anticancer Res; 2007; 27(4C):3019-24. PubMed ID: 17695490
[TBL] [Abstract][Full Text] [Related]
23. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK
J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656
[TBL] [Abstract][Full Text] [Related]
24. Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and Fluorouracil chemotherapy, surgery, and radiotherapy: long-term results.
Ardavanis A; Scorilas A; Tryfonopoulos D; Orphanos G; Missitzis I; Karamouzis M; Chrysochoou M; Sotiropoulou A; Arnogiannaki N; Ioannidis G; Pissakas G; Rigatos G
Oncologist; 2006 Jun; 11(6):563-73. PubMed ID: 16794236
[TBL] [Abstract][Full Text] [Related]
25. [Condensed chemotherapy in breast neoplasms. Results of once-a-day venous perfusion administration of a triple combination].
Chauvergne J; Durand M; Hoerni B; Mauriac L; David M
Bull Cancer; 1986; 73(3):316-8. PubMed ID: 3756368
[No Abstract] [Full Text] [Related]
26. Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study.
Ardavanis A; Mavroudis D; Kalbakis K; Malamos N; Syrigos K; Vamvakas L; Kotsakis A; Kentepozidis N; Kouroussis C; Agelaki S; Georgoulias V;
Cancer Chemother Pharmacol; 2006 Dec; 58(6):742-8. PubMed ID: 16718470
[TBL] [Abstract][Full Text] [Related]
27. [A case of unresectable advanced gallbladder cancer treated by systemic chemotherapy combined with hepatic arterial infusion].
Ishiguro A; Munakata M; Shitara K; Suzuki K; Takahata T; Itoh J; Sakata Y; Munakata A
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1127-30. PubMed ID: 17637555
[TBL] [Abstract][Full Text] [Related]
28. Dose-dense adjuvant chemotherapy for node-positive breast cancer in women 60 years and older: feasibility and tolerability in a subset of patients in a randomized trial.
Kümmel S; Krocker J; Kohls A; Breitbach GP; Morack G; Budner M; Blohmer JU; Lichtenegger W; Elling D
Crit Rev Oncol Hematol; 2006 May; 58(2):166-75. PubMed ID: 16387512
[TBL] [Abstract][Full Text] [Related]
29. [Successful antiemetic treatment of TSUMURA Rikkunshi-to Extract Granules for ethical use in addition to other antiemetic agents in neoadjuvant chemotherapy for an advanced breast cancer patient].
Tomono H; Ito Y; Watanabe T
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1129-31. PubMed ID: 16912533
[TBL] [Abstract][Full Text] [Related]
30. [A case of carcinomatous cardiac tamponade due to breast cancer treated with OK-432 and mitomycin C].
Wakiyama S; Shirabe K; Nagaie T
Gan To Kagaku Ryoho; 2007 Mar; 34(3):439-41. PubMed ID: 17353639
[TBL] [Abstract][Full Text] [Related]
31. Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer.
Gennari A; Amadori D; De Lena M; Nanni O; Bruzzi P; Lorusso V; Manzione L; Conte PF
J Clin Oncol; 2006 Aug; 24(24):3912-8. PubMed ID: 16921042
[TBL] [Abstract][Full Text] [Related]
32. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
[TBL] [Abstract][Full Text] [Related]
33. Feasibility of radiotherapy after high-dose dense chemotherapy with epirubicin, preceded by dexrazoxane, and paclitaxel for patients with high-risk Stage II-III breast cancer.
De Giorgi U; Giannini M; Frassineti L; Kopf B; Palazzi S; Giovannini N; Zumaglini F; Rosti G; Emiliani E; Marangolo M
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1165-9. PubMed ID: 16682141
[TBL] [Abstract][Full Text] [Related]
34. Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women > or = 65 years of age.
Addeo R; Faiola V; Guarrasi R; Montella L; Vincenzi B; Capasso E; Cennamo G; Rotundo MS; Tagliaferri P; Caraglia M; Del Prete S
Cancer Chemother Pharmacol; 2008 Jul; 62(2):285-92. PubMed ID: 17922275
[TBL] [Abstract][Full Text] [Related]
35. Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel.
Torrisi R; Balduzzi A; Ghisini R; Rocca A; Bottiglieri L; Giovanardi F; Veronesi P; Luini A; Orlando L; Viale G; Goldhirsch A; Colleoni M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):667-72. PubMed ID: 18064460
[TBL] [Abstract][Full Text] [Related]
36. [Safety and efficacy of weekly paclitaxel followed by FEC100 as primary systemic therapy for breast cancer].
Naito K; Oura S; Yoshimasu T; Tamaki T; Ohta F; Nakamura R; Shimizu Y; Kiyoi M; Hirai Y; Miyasaka M; Okamura Y
Gan To Kagaku Ryoho; 2009 Feb; 36(2):251-4. PubMed ID: 19223740
[TBL] [Abstract][Full Text] [Related]
37. Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes.
Tanabe M; Ito Y; Tokudome N; Sugihara T; Miura H; Takahashi S; Seto Y; Iwase T; Hatake K
Breast Cancer; 2009; 16(4):301-6. PubMed ID: 19205831
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy for breast cancer. Part 2: Treatment of metastatic breast cancer.
Hill GJ
W V Med J; 1986 Aug; 82(8):267-9. PubMed ID: 3463009
[No Abstract] [Full Text] [Related]
39. Current management of advanced breast cancer.
Hortobagyi GN; Piccart-Gebhart MJ
Semin Oncol; 1996 Oct; 23(5 Suppl 11):1-5. PubMed ID: 8893891
[No Abstract] [Full Text] [Related]
40. [Combined chemotherapy of metastatic cancer of the breast].
Izmaĭlova GE; Letiagin VP; Starikova AB
Sov Med; 1988; (4):91-4. PubMed ID: 3406828
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
